CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Aug. 31, 2025	Aug. 31, 2024
Cash flows used in operating activities
Net loss	$ (11,911,434)	$ (5,808,654)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation	859,494	492,236
Depreciation and amortization	87,825	76,153
Impairment loss	247,364	57,836
Bad debt expense	0	7,760
Noncash lease expense	28,027	32,603
Unrealized loss on marketable securities	33,714	69,835
Lease accretion	9,047	6,672
Change in operating assets and liabilites:
Accounts receivable	(213,881)	(35,551)
Prepaid expenses and deposits	55,313	(641,034)
Long-term receivables	(438)	(15,016)
Accounts payable and accrued liabilities	396,637	826,468
Operating lease liability	(37,093)	(33,273)
Deferred revenue	(4,962)	4,962
Net cash used in operating activities	(10,450,387)	(4,959,003)
Cash flows used in investing activities
Short-term investments	(143,267)	0
Additions to intellectual property	(75,106)	(145,591)
Purchase of equipment	(24,646)	(43,014)
Net cash used in investing activities	(243,019)	(188,605)
Cash flows provided by financing activities
Proceeds from exercise of stock options	0	2,875
Proceeds from shares sold for cash	6,046,163	4,208,731
Proceeds from exercise of warrants	0	6,103,601
Net cash provided by financing activities	6,046,163	10,315,207
Effect of exchange rate changes on cash	(50,519)	(19,816)
Net change in cash for the period	(4,697,762)	5,147,783
Cash at beginning of period	6,499,885	1,352,102
Cash at end of period	$ 1,802,123	$ 6,499,885